Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells

Biomacromolecules

Volumn 8, Issue 1, 2007, Pages 13-18

  Myc, Andrzej ^a   Majoros, István J ^a   Thomas, Thommey P ^a   Baker Jr , James R ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; FLUORESCENCE; MOLECULES; NANOSTRUCTURED MATERIALS; ONCOLOGY;

APOPTOSIS; FLUORESCENCE RESPONSE ENERGY TRANSFER; POLYAMIDOAMINE;

DENDRIMERS;

ANTINEOPLASTIC AGENT; CASPASE; DENDRIMER; FOLIC ACID; POLYAMIDOAMINE; REAGENT; STAUROSPORINE;

APOPTOSIS; ARTICLE; BIOENGINEERING; CANCER CELL; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYME ACTIVATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; NANODEVICE; PRIORITY JOURNAL; STRUCTURE ANALYSIS; SYNTHESIS; TARGET CELL;

APOPTOSIS; CELL LINE, TUMOR; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DENDRIMERS; DRUG DELIVERY SYSTEMS; ELECTROCHEMISTRY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; HYDROLYSIS; JURKAT CELLS; MODELS, CHEMICAL; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS;

EID: 33846456200     PISSN: 15257797     EISSN: None     Source Type: Journal    
DOI: 10.1021/bm060815l     Document Type: Article

References (19)

1. Majoros, I. J.; Thomas, T. P.; Baker, J. R., Jr. Bioinformatics, nanomedicine and drug delivery. In Handbook of Theoretical and Computational Nanotechnology; American Scientific Publishers: Stevenson Ranch, CA, 2006; Vol 6.
2. Svenson, S.; Tomalia, D. A. Dendrimers in biomedical applications-Reflections on the field. Adv. Drug Delivery Rev. 2005, 57, 2106-2129.
3. Quintana, A.; Raczka, E.; Piehler, L.; Lee, I.; Myc, A.; Majoros, I.; Patri, A. K.; Thomas, T.; Mule, J.; Baker, J. R., Jr. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res. 2002, 19, 1310-1316.
4. Thomas, T. P.; Majoros, I. J.; Kotlyar, A.; Kukowska-Latallo, J. F.; Bielinska, A.; Myc, A.; Baker, J. R., Jr. Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J. Med. Chem. 2005, 48, 3729-3735.
5. Majoros, I. J.; Thomas, T. P.; Mehta, C. B.; Baker, J. R., Jr. Poly-(amidoamine) dendrimer-based multifunctional engineered nano-device for cancer therapy. J. Med. Chem 2005, 48, 5892-5899.
6. Kukowska-Latallo, J. F.; Candido, K. A.; Cao, Z.; Nigavekar, S. S.; Majoros, I. J.; Thomas, T. P.; Balogh, L. P.; Khan, M. K.; Baker, J. R., Jr. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 2005, 65, 5317-5324.
7. Thomas, T. P.; Patri, A. K.; Myc, A.; Myaing, M. T.; Ye, J. Y.; Norris, T. B.; Baker, J. R., Jr. In vitro targeting of synthesized antibody-conjugated dendrimer nanoparticles. Biomacromolecules 2004, 5, 2269-2274.
8. Patri, A. K.; Myc, A.; Beals, J.; Thomas, T. P.; Bander, N. H.; Baker, J. R., Jr. Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy. Bioconjugate Chem. 2004, 15, 1174-1181.
9. Shukla, R.; Thomas, T. P.; Peters, J. L.; Kukowska-Latano, J. F.; Patri, A. K.; Kotlyar, A.; Myc, A.; Baker, J. R., Jr. Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates. Chem Commun. 2005, 46, 5739-5741.
10. Vermeulen, K.; Van Bockstaele, D. R.; Berneman, Z. N. Apoptosis: Mechanisms and relevance in cancer. Ann. Hematol. 2005, 84, 627-639.
11. Cornelissen, B.; Lahorte, C.; Kersemans, V.; Capriotti, G.; Bonanno, E.; Signore, A.; Van de Wiele, C.; Dierckx, R. A.; Slegers, G. In vivo apoptosis detection with radioiodinated Annexin V in LoVo tumour-bearing mice following Tipifarnib (Zarnestra, R115777) farnesyltransferase inhibitor therapy. Nucl. Med. Biol. 2005, 32, 233-239.
12. Darzynkiewicz, Z.; Huang, X.; Okafuji, M.; King, M. A. Cytometric methods to detect apoptosis. Methods Cell Biol. 2004, 75, 307-341.
13. Wyllie, A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980, 284, 555-556.
14. Pozarowski, P.; Huang, X.; Halicka, D. H.; Lee, B.; Johnson, G.; Darzynkiewicz, Z. Interactions of fluorochrome-labeled caspase inhibitors with apoptotic: cells: A caution in data interpretation. Cytometry 2003, 55A, 50-60.
15. Belloc, F.; Belaud-Rotureau, M. A.; Lavignolle, V.; Bascans, E.; Braz-Pereira, E.; Durrieu, F.; Lacombe, F. Flow cytometry detection of caspase 3 activation in preapoptotic leukemic cells. Cytometry 2000, 40, 151-160.
16. Thomas, T. P.; Myaing, M. T.; Ye, J. Y.; Candido, K.; Kotlyar, A.; Beals, J.; Cao, P.; Keszler, B.; Norris, T. B.; Baker J. R., Jr. Detection and analysis of tumor fluorescence using a two-photon optical fiber probe. Biophys. J. 2004, 86, 3959-3965.
17. Antony, A. C.; Kane, M. A.; Portillo, R. M.; Elwood, P. C.; Kolhouse, J. F. Studies of the role of a particulate folate-binding protein in the uptake of 5-methylteftuhydrofolate by cultured human KB cells. J. Biol. Chem. 1985, 260, 14911-14917.
18. Esfand, R.; Tomalia, D. A. Poly(amidoamine) (PAMAM) dendrimers: From biomimicry to drug delivery and biomedical application. Drug Discovery Today 2001, 6, 427-436.
19. Majoros, I. J.; Mehta, C. B.; Baker, J. R., Jr. Mathematical Description of Dendrimer Structure. J. Comput. Theor. Nanosci. 2004, 1, 193-198.